185 related articles for article (PubMed ID: 2737600)
1. Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis.
Mayet WJ; Hess G; Gerken G; Rossol S; Voth R; Manns M; Meyer zum Büschenfelde KH
Hepatology; 1989 Jul; 10(1):24-8. PubMed ID: 2737600
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies during alpha-interferon therapy for chronic hepatitis B.
Fattovich G; Betterle C; Brollo L; Pedini B; Giustina G; Realdi G; Alberti A; Ruol A
J Med Virol; 1991 Jun; 34(2):132-5. PubMed ID: 1890413
[TBL] [Abstract][Full Text] [Related]
3. Interferon-alpha therapy may induce insulin autoantibody development in patients with chronic viral hepatitis.
di Cesare E; Previti M; Russo F; Brancatelli S; Ingemi MC; Scoglio R; Mazzù N; Cucinotta D; Raimondo G
Dig Dis Sci; 1996 Aug; 41(8):1672-7. PubMed ID: 8769300
[TBL] [Abstract][Full Text] [Related]
4. No evidence of autoimmunity in 6-year-old children immunized at birth with recombinant hepatitis B vaccine.
Belloni C; Avanzini MA; De Silvestri A; Martinetti M; Pasi A; Coslovich E; Autelli M; Masanti ML; Cuccia M; Tinelli C; Rondini G; Lorini R
Pediatrics; 2002 Jul; 110(1 Pt 1):e4. PubMed ID: 12093985
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis.
Imagawa A; Itoh N; Hanafusa T; Oda Y; Waguri M; Miyagawa J; Kono N; Kuwajima M; Matsuzawa Y
J Clin Endocrinol Metab; 1995 Mar; 80(3):922-6. PubMed ID: 7883851
[TBL] [Abstract][Full Text] [Related]
7. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
Chung YH; Shong YK
Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies and response to alpha-interferon in patients with chronic viral hepatitis.
Saracco G; Touscoz A; Durazzo M; Rosina F; Donegani E; Chiandussi L; Gallo V; Petrino R; De Micheli AG; Solinas A
J Hepatol; 1990 Nov; 11(3):339-43. PubMed ID: 2127054
[TBL] [Abstract][Full Text] [Related]
9. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors.
Rönnblom LE; Alm GV; Oberg KE
Ann Intern Med; 1991 Aug; 115(3):178-83. PubMed ID: 2058872
[TBL] [Abstract][Full Text] [Related]
10. Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients.
Floreani A; Chiaramonte M; Greggio NA; Fabris P; De Lazzari F; Naccarato R; Betterle C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):71-6. PubMed ID: 9615270
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies before, during and after administration of recombinant interferon-alpha for chronic viral hepatitis.
Lopes EP; Silva AE; Sette Junior H; Guimarães RX; Ferraz ML
Rev Inst Med Trop Sao Paulo; 1995; 37(5):455-60. PubMed ID: 8729757
[TBL] [Abstract][Full Text] [Related]
12. Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B.
Cianciara J; Laskus T
Dig Dis Sci; 1995 Aug; 40(8):1842-4. PubMed ID: 7648989
[TBL] [Abstract][Full Text] [Related]
13. Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa.
Gregorio GV; Jones H; Choudhuri K; Vegnente A; Bortolotti F; Mieli-Vergani G; Vergani D
Hepatology; 1996 Sep; 24(3):520-3. PubMed ID: 8781317
[TBL] [Abstract][Full Text] [Related]
14. Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.
Betterle C; Fabris P; Zanchetta R; Pedini B; Tositti G; Bosi E; de Lalla F
Diabetes Care; 2000 Aug; 23(8):1177-81. PubMed ID: 10937518
[TBL] [Abstract][Full Text] [Related]
15. [Interferon alpha antibodies show no cross reactions with typical autoantibodies].
Görg S; Klouche M; Wilhelm D; Kirchner H
Immun Infekt; 1993 Apr; 21 Suppl 1():54-6. PubMed ID: 8344695
[TBL] [Abstract][Full Text] [Related]
16. Induction of autoimmune phenomena in patients with chronic hepatitis B treated with gamma-interferon.
Weber P; Wiedmann KH; Klein R; Walter E; Blum HE; Berg PA
J Hepatol; 1994 Mar; 20(3):321-8. PubMed ID: 7516948
[TBL] [Abstract][Full Text] [Related]
17. Thyroid autoantibodies and thyroid dysfunction during treatment with interferon-alpha for chronic hepatitis C.
Kiehne K; Kloehn S; Hinrichsen H; Gallwitz B; Mönig H
Endocrine; 1997 Jun; 6(3):231-4. PubMed ID: 9368677
[TBL] [Abstract][Full Text] [Related]
18. [Autoantibodies related to interferon therapy in chronic hepatitis B may affect the therapeutic response to interferon].
Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M; Kashima K
Nihon Shokakibyo Gakkai Zasshi; 1991 Nov; 88(11):2771-7. PubMed ID: 1722518
[TBL] [Abstract][Full Text] [Related]
19. Serological markers of autoimmunity in renal transplant patients before and after alpha-interferon therapy for chronic hepatitis C.
Rostaing L; Oksman F; Izopet J; Baron E; Cisterne JM; Hoff M; Abbal M; Durand D
Am J Nephrol; 1996; 16(6):478-83. PubMed ID: 8955758
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of autoimmunity markers during interferon alpha therapy of chronic hepatitis B and C - twenty years of experience].
Orságová I; RoŽnovský L; Petroušová L; Konečná M; Kabieszová L; Martinek J; Kloudová A; Pavliska L
Klin Mikrobiol Infekc Lek; 2016 Jun; 22(2):61-7. PubMed ID: 27450524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
